MDT Stock Sentiment Today: BULLISH

Medtronic plc · HEALTHCARE · AI news analysis · updated 2026-09-01

Medtronic faces imminent Q1 earnings (Sept. 1) with strong analyst support, evidenced by two recent price target raises to $110 and $114 from TD Cowen and Needham respectively. The company's 3.16% dividend yield and Dividend Aristocrat status appeal to income investors, though near-term volatility around earnings is expected.

Key themes driving MDT sentiment

Recent headlines behind the verdict

• Needham Maintains Buy on Medtronic, Raises Price Target to $114
  Benzinga — Analyst upgrade with price target raised $13 to $114, signaling confidence ahead of earnings and implying 25% upside from recent lows.
• TD Cowen Maintains Buy on Medtronic, Raises Price Target to $110
  Benzinga — Second consecutive analyst raise within 24 hours, with TD Cowen lifting target to $110 from $100, demonstrating sustained conviction.
• How To Earn $500 A Month From Medtronic Stock Ahead Of Q1 Earnings
  Benzinga — Highlights dividend income opportunity with 3.16% yield and upcoming earnings catalyst, appealing to income-focused investors.
• Medtronic Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
  Benzinga — Reports consensus forecasts ($1.39 EPS, $9.54B revenue) with recent stock weakness (2.2% decline), indicating potential volatility ahead of earnings.
• Best Dividend Aristocrats For September 2026
  SeekingAlpha — Dividend Aristocrat recognition and near-parity performance with SPY indicate MDT's resilience and attractiveness for dividend growth portfolios.
• 10 Health Care Stocks Whale Activity In Today's Session
  Benzinga — Signals institutional interest in healthcare sector including MDT, though specific directional bias unclear without transaction details.

Sentiment reflects AI analysis of published news headlines as of 2026-09-01 and can change at any time. For informational purposes only · Not financial advice · signalsentiment.com